| Ytd | -90.89% | |
| 1y | -92.22% |
| Open | 1.14 | Prev Close | 1.15 | Low | 1.10 | High | 1.23 | Mkt Cap | 4.34M |
| Vol | 359.62K | Avg Vol | 757.70K | EPS | -9.16 | P/E | N/A | Forward P/E | 0.02 |
| Beta | -1.04 | Short Ratio | 0.39 | Inst. Own | 1.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.61 | 200-d Avg | 8.39 | 1yr Est | 300.00 |
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company spec
FORT LAUDERDALE, FL / ACCESS Newswire / August 31, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company offe
K1.1 mRNA demonstrated tumor-suppressing activity as a single agent in multiple in vivo hepatocellul
Sunshine Biopharma outlines K1.1 mRNA pipeline updates, advancing dual oncology therapy to target co
Global anti-hypertensive drug market projected to reach $37.24 billion by 2034Enalapril is a widely
Global anti-hypertensive drug market projected to reach $37.24 billion by 2034 Enalapril is a widely
Sunshine Biopharma secures Canadian regulatory approval for generic Enalapril tablets to treat high
Sunshine Biopharma's Amoxicillin now shipping to Canadian pharmacies in multiple dosages and strengt
Dienogest is first-line therapy for pelvic pain associate with endometriosis The endometriosis treat
Pharmaceutical firm Sunshine Biopharma Inc. (NASDAQ:SBFM) on Tuesday said it received regulatory app
Sunshine Biopharma secures Canadian approval for its generic 2mg Dienogest tablets, expanding into w
Sunshine Biopharma (NASDAQ: SBFM - Get Free Report) and Foghorn Therapeutics (NASDAQ: FHTX - Get Fre
FORT LAUDERDALE, FL / ACCESS Newswire / July 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday&
FORT LAUDERDALE, FL / ACCESS Newswire / July 20, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "
Sunshine Biopharma, Inc. (NASDAQ: SBFM - Get Free Report) saw a significant drop in short interest i
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company spec
FORT LAUDERDALE, FL / ACCESS Newswire / June 25, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "
HPE stock jumps 26.55% after reporting strong revenue growth. Top gainers are DXST, MRVL and more. T
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company spec
FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "C
FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "C
Sunshine Biopharma stock fell after hours after the company announced a 1-for-10 reverse stock split
Sunshine Biopharma stock fell after hours after the company announced a 1-for-10 reverse stock split
U.S. stocks rise, Dow Jones gains 200 points. NASDAQ up 0.73%, S&P 500 up 0.56%. Health care sha
FORT LAUDERDALE, FL / ACCESS Newswire / May 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "C
Sunshine Biopharma (NASDAQ: SBFM) shares are trading higher Thursday after securing Canadian regulat
Sunshine Biopharma (NASDAQ: SBFM) shares are trading higher Thursday after securing Canadian regulat
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company spec
FORT LAUDERDALE, FL / ACCESS Newswire / May 21, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "C
Shares of 8x8 Inc (NASDAQ: EGHT) jumped 13.3% in pre-market trading after reporting better-than-expe
$6.0 million upfront with up to an additional approximately $12.0 million of potential aggregate gro
SBFM stock plummets 18% in premarket trading after Sunshine Biopharma prices a $6M public offering a
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and
US stocks lower as Nasdaq falls 200 points, Dow down 0.04% and S&P 500 down 0.37%. Energy shares
FORT LAUDERDALE, FL / ACCESS Newswire / May 18, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "C
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $